Oxidative Stress in Myocardial Remodeling and Failure
Project Number5R01HL064750-03
Contact PI/Project LeaderCOLUCCI, WILSON S.
Awardee OrganizationBOSTON MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (the applicant's description verbatim): Reactive oxygen species
(ROS) are increased in the myocardium coincident with the progression to left
ventricular (LV) systolic failure. In cardiac myocytes in vitro, we have found
that ROS can mimic the cellular events observed in myocardial remodeling, and
that the hypertrophic and apoptotic effects of adrenergic stimulation and
mechanical strain are ROS-dependent. We will use a combination of in vitro, in
vivo and ex vivo methods to test our central hypothesis that ROS play a
critical role in mediating the effects of excessive adrenergic stimulation and
mechanical overload on myocardial phenotype. We will use adult rat ventricular
myocytes in vitro 1) to elucidate the roles of the quantity and specific types
of ROS (e.g., O2, H2O2 and OH) in mediating the effects of adrenergic
stimulation and mechanical strain on myocyte phenotype, and 2) to determine the
source of ROS in response to adrenergic stimulation and mechanical strain.
Building on these in vitro experiments, we will test our central hypothesis in
vivo using transgenic mice that exhibit an apoptotic phenotype due to
myocardial overexpression of beta1AR or a hypertrophic phenotype due to
overexpression of Galphaq, the primary G protein coupled to alpha1AR and
mechanical strain. To test the role of ROS in mediating the myocardial
phenotypes in these models, ROS levels will be decreased by cross-breeding with
mice that express increased levels of the antioxidant enzymes manganese
superoxide dismutase (MnSOD) or Cu/ZnSOD. The primary endpoints for these
experiments will be fundamental measures of remodeling at the structural and
functional level - LV chamber dilation and contractile function. Secondary
endpoints will be important cellular events that have been implicated in
myocardial remodeling - hypertrophy, fetal program expression and apoptosis in
cardiac myocytes, and activation of metalloproteinases in cardiac fibroblasts.
The interpretation of these experiments will be aided by measurement of ROS by
electroparamagnetic resonance and cellular redox state by the ratio of reduced
to oxidized glutathione. These studies offer to provide new mechanistic
understanding of the process of myocardial remodeling.
No Sub Projects information available for 5R01HL064750-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL064750-03
Patents
No Patents information available for 5R01HL064750-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL064750-03
Clinical Studies
No Clinical Studies information available for 5R01HL064750-03
News and More
Related News Releases
No news release information available for 5R01HL064750-03
History
No Historical information available for 5R01HL064750-03
Similar Projects
No Similar Projects information available for 5R01HL064750-03